Infant Health And Immunization Episodes
Dec. 10, 2025
1040: Michigan’s Chief Medical Executive Discusses the Stakes of ACIP’s Vote on Hepatitis B Vaccine for Newborns
In this episode, ASTHO member and Michigan Department of Health & Human Services Chief Medical Executive Dr. Natasha Bagdasarian breaks down a major development in national vaccine policy: the CDC Advisory Committee on Immunization Practices' (ACIP’s) decision to narrow its guidance on the hepatitis B vaccine for newborns.
Guest: Natasha Bagdasarian, MD, MPH
Dec. 1, 2025
1034: Public Health at a Crossroads: Trust, Storytelling, and the Future of the Field
ASTHO's Chief Medical Officer, Dr. Susan Kansagra, joins us for a candid conversation about the state of public health today. She reflects on her unexpected path into the field, the urgent need to rebuild public trust, and why communicating the everyday value of public health is more critical than ever. Dr. Kansagra also explores how social media, new messengers, and emerging tools like AI can help reshape engagement, boost impact, and energize a workforce facing growing pressure. A motivating reminder that public health is a marathon, not a sprint, and that meaningful progress takes time, partnership, and persistence.
Guest: Susan Kansagra, MD, MBA
Nov. 12, 2025
1027: RSV Season Update: Data Gaps, Trends, and Immunization Efforts
Dr. Susan Kansagra, chief medical officer at ASTHO, shares an update on rising RSV activity and how states are tracking trends during the federal shutdown. She highlights new tools that protect infants, including maternal vaccines and monoclonal antibodies, and explains how public health and birthing hospitals are partnering to expand access through the Vaccines for Children program. Early results show increased hospital enrollment and fewer RSV-related hospitalizations among infants.
Guest: Susan Kansagra, MD, MBA
293
June 11, 2024
683: RSV Season Preps Underway, Tips to Build PH Trust
Dr. Michelle Fiscus, chief medical officer at the Association of Immunization Managers, discusses numbers released in March that show the RSV immunization for infants is 90 percent effective; Dr. Tom Frieden, president and chief executive officer of...